Breast Cancer Trial, Recruiting (NCT07008339)

Breast Cancer Trial, Recruiting NCT07008339 Sponsor: Germans Trias i Pujol Hospital Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07008339 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women aged 18 or older, or younger women whose parent or legal guardian has given consent
Women having their first nipple and areola area reconstruction using a skin-colouring/tattooing technique (micropigmentation)
Women who have not previously had surgery to create a new nipple, on one or both sides
Women who have had the areola (the darker skin around the nipple) rebuilt through surgery
Women who have had a new nipple built through surgery, but where the nipple has since shrunk back or retracted
Women who have had their most recent surgery more than 6 months ago

Who may not be able to join:

Women who have an allergy to hyaluronic acid (a substance commonly used in medical and cosmetic treatments)
Women who have difficulty tolerating needle injections
Participants may also be removed from the trial if they choose to withdraw, experience complications related to the procedure (such as an allergic reaction or bruising), or if their health declines in a way that prevents them from continuing

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ariadna Huertas Zurriaga, RN, Germans Trias i Pujol Hospital

Phone: +34 695161506

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07008339

Sponsor: Germans Trias i Pujol Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: +34 695161506

More information: https://clinicaltrials.gov/study/NCT07008339

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women aged 18 or older, or younger women whose parent or legal guardian has given consent
Women having their first nipple and areola area reconstruction using a skin-colouring/tattooing technique (micropigmentation)
Women who have not previously had surgery to create a new nipple, on one or both sides
Women who have had the areola (the darker skin around the nipple) rebuilt through surgery
Women who have had a new nipple built through surgery, but where the nipple has since shrunk back or retracted
Women who have had their most recent surgery more than 6 months ago

Who may not be able to join:

Women who have an allergy to hyaluronic acid (a substance commonly used in medical and cosmetic treatments)
Women who have difficulty tolerating needle injections
Participants may also be removed from the trial if they choose to withdraw, experience complications related to the procedure (such as an allergic reaction or bruising), or if their health declines in a way that prevents them from continuing

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Germans Trias i Pujol Hospital

Registry

ClinicalTrials.gov

Start date

2 June 2023

Est. completion

2 June 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Satisfaction with Nipple Reconstruction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov